XYOTAX

Swiss trademark · 504517 · Word mark · Deleted

Register entry

Registration number
504517
Application number
07347/2002
Status
Deleted
Type
Word mark
Filed
Aug 23, 2002
Registered
Oct 24, 2002
Published
Nov 7, 2002
Deleted
Mar 25, 2013
Reason
Not renewed
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate, namentlich Arzneimittel zur Behandlung von Krebs.

Science, technology and IT

Entwicklung pharmazeutischer Präparate und Arzneimittel sowie Dienstleistungen zu deren Kommerzialisierung, namentlich auf dem Gebiet der Behandlung von Krebs.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 25, 2013

    Deleted, not renewed

    Published in Swissreg on 25.03.2013

  2. Jun 18, 2007

    Transferred

    Owner
    Cell Therapeutics, Inc., 501 Elliott Avenue West, Suite 400, Seattle (WA 98119), USA → Novartis AG, 4002 Basel
    Representative
    Jacobacci & Partners S.A., 2, avenue de la Gare des Eaux-Vives, 1207 Genève → NOVARTIS INTERNATIONAL AG, Corporate Intellectual Property, Global Trademark Section, 4002 BASEL

    Published in the SOGC no. 115 of 18.06.2007

  3. Jul 17, 2006

    Agent entered

    Representative
    Braun & Partner, Reussstrasse 22, 4054 Basel → Jacobacci & Partners S.A., 2, avenue de la Gare des Eaux-Vives, 1207 Genève

    Published in the SOGC no. 136 of 17.07.2006

  4. Nov 7, 2002

    Registered

    Published in the SOGC no. 216 of 07.11.2002

Parties

Holder

Novartis AG

4002 Basel

Agent

Novartis International AG

NOVARTIS INTERNATIONAL AG Corporate Intellectual Property Global Trademark Section

4002 BASEL

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.